Sudbury Vertigo Risk Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
sudbury score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk-4–4
  • Moderate Risk5–8
  • High Risk9–17
Direct Clinical Answer

The Sudbury Vertigo Risk Score calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include male sex. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Identifies vertigo patients at higher risk for serious central diagnosis including stroke, TIA, vertebral artery dissection, or brain tumor in the emergency department setting.

Clinical Indication

The Sudbury Vertigo Risk Score is indicated for bedside clinical practice to support Identifies vertigo patients at higher risk for serious central diagnosis including stroke, TIA, vertebral artery dissection, or brain tumor in the emergency department setting.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis. Clinical exclusion: Not applicable for patients with episodic vertigo lasting <24 hours.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: External validation showed 100% sensitivity and 69.2% specificity for score <5.

Formula & Variables:

Score = Sum of points for: Male sex + Age >65 + Hypertension + Diabetes + Motor/sensory deficits + Cerebellar signs - BPPV diagnosis. Range: -4 to 17 points.

Input Parameters

NameTypeRequiredDescription
male_sexstringYesPatient is male
age_over_65stringYesPatient age is over 65 years
hypertensionstringYesHistory of hypertension
diabetesstringYesHistory of diabetes mellitus
motor_sensory_deficitsstringYesMotor or sensory deficits on examination
cerebellar_signsstringYesCerebellar signs/symptoms (diplopia, dysarthria, dysphagia, dysmetria, ataxia)
bppv_diagnosisstringYesClinical diagnosis of benign paroxysmal positional vertigo (BPPV)

Score Interpretation & Guidance

RangeStageDescription
-4–4Low Risk0% risk of serious diagnosis
5–8Moderate Risk2.1% risk of serious diagnosis
9–17High Risk41% risk of serious diagnosis

Evidence-Based References (EBM)

  • Lelli D, Dinh J, Ahuja N, et al. Development of a Clinical Risk Score to Risk Stratify for a Serious Cause of Vertigo in Patients Presenting to the Emergency Department. Ann Emerg Med. 2024 Nov;84(5):500-511. doi: 10.1016/j.annemergmed.2024.06.003.DOI: 10.1016/j.annemergmed.2024.06.003
  • de Guise C, Chagnon M, Boudier-Revéret M, et al. Validation of the Sudbury Vertigo Risk Score to risk stratify for a serious cause of vertigo. Acad Emerg Med. 2024 Dec;31(12):1218-1227. doi: 10.1111/acem.14950.DOI: 10.1111/acem.14950
  • Newman-Toker DE, Edlow JA. TiTrATE: A Novel, Evidence-Based Approach to Diagnosing Acute Dizziness and Vertigo. Neurol Clin. 2015 Aug;33(3):577-99. doi: 10.1016/j.ncl.2015.04.011.DOI: 10.1016/j.ncl.2015.04.011

Related calculators